RT Journal Article
SR Electronic
T1 Effectiveness of “Reducing Disability in Alzheimer’s Disease” among dyads with moderate dementia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.07.20056705
DO 10.1101/2020.04.07.20056705
A1 Perales-Puchalt, Jaime
A1 Barton, Kelli
A1 Ptomey, Lauren T
A1 Niedens, C. Michelle
A1 Yeager, Amy
A1 Gilman, Laura
A1 Seymour, Pam
A1 George, Amanda
A1 Sprague, Susan C.
A1 Neira, Antonio Mirás
A1 Van Dyke, Rik
A1 Teri, Linda
A1 Vidoni, Eric D
YR 2020
UL http://medrxiv.org/content/early/2020/04/11/2020.04.07.20056705.abstract
AB Interventions such as Reducing Disability in Alzheimer’s Disease (RDAD) improve the health of care receiver-caregiver dyads but plans to implement it locally in regional community agencies yielded three changes: 1) reduced reliance on licensed clinicians, 2) centralized exercise interventionists and 3) more flexible delivery. We aimed to assess the effectiveness of the Kansas City RDAD implementation (RDAD-KC) among a non-probabilistic sample of dyads with moderate dementia, which addressed these changes. We hypothesized that dyads’ health would improve from baseline to the end-of-treatment. Outcomes improved (p<0.01) from pre to post-intervention: Behavioral symptom severity (range 0-36) decreased from 11.3 to 8.6, physical activity increased from 125.0 to 190.0 minutes/week, caregiver unmet needs (range 0-34) decreased from 10.6 to 5.6, caregiver behavioral symptom distress (0-60) decreased from 15.5 to 10.4 and caregiver strain (0-26) decreased from 11.1 to 9.7. This adapted implementation of RDAD leads to clinically meaningful improvements and might inform scaling-up.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFindings reported in this project were supported by the Administration for Community Living under Cooperative Agreement Award Number 90KSALGG0009. The sponsors defined the dementia severity required for individuals to participate in the project. The research reported in this publication was partly supported by the National Institute on Aging of the National Institutes of Health under Award Number P30AG035982.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, upon reasonable request.